Annual FCF
-$96.57 M
-$19.37 M-25.09%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual free cash flow is -$96.57 million, with the most recent change of -$19.37 million (-25.09%) on December 31, 2023.
- During the last 3 years, XFOR annual FCF has fallen by -$36.39 million (-60.47%).
- XFOR annual FCF is now -779.05% below its all-time high of -$10.99 million, reached on December 31, 2015.
Performance
XFOR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$34.12 M
+$3.29 M+8.79%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly free cash flow is -$34.12 million, with the most recent change of +$3.29 million (+8.79%) on September 30, 2024.
- Over the past year, XFOR quarterly FCF has increased by +$3.29 million (+8.79%).
- XFOR quarterly FCF is now -504.74% below its all-time high of $8.43 million, reached on December 31, 2018.
Performance
XFOR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$132.97 M
-$13.29 M-11.10%
September 30, 2024
Summary
- As of February 12, 2025, XFOR TTM free cash flow is -$132.97 million, with the most recent change of -$13.29 million (-11.10%) on September 30, 2024.
- Over the past year, XFOR TTM FCF has dropped by -$13.29 million (-11.10%).
- XFOR TTM FCF is now -3669.08% below its all-time high of -$3.53 million, reached on March 31, 2017.
Performance
XFOR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
XFOR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.1% | +8.8% | -11.1% |
| 3 y3 years | -60.5% | +8.8% | -11.1% |
| 5 y5 years | -279.9% | -165.5% | -175.7% |
XFOR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.0% | at low | -84.3% | +8.8% | -85.9% | at low |
| 5 y | 5-year | -100.2% | at low | -266.0% | +8.8% | -175.7% | at low |
| alltime | all time | -779.0% | at low | -504.7% | +8.8% | -3669.1% | at low |
X4 Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$34.12 M(-8.8%) | -$132.97 M(+11.1%) |
| Jun 2024 | - | -$37.41 M(+11.2%) | -$119.69 M(+15.4%) |
| Mar 2024 | - | -$33.66 M(+21.1%) | -$103.71 M(+7.4%) |
| Dec 2023 | -$96.57 M(+25.1%) | -$27.78 M(+33.3%) | -$96.57 M(+9.8%) |
| Sep 2023 | - | -$20.84 M(-2.8%) | -$87.92 M(+1.8%) |
| Jun 2023 | - | -$21.43 M(-19.2%) | -$86.40 M(+3.5%) |
| Mar 2023 | - | -$26.52 M(+38.7%) | -$83.47 M(+8.1%) |
| Dec 2022 | -$77.20 M(+7.9%) | -$19.13 M(-1.0%) | -$77.20 M(+0.1%) |
| Sep 2022 | - | -$19.32 M(+4.3%) | -$77.14 M(+7.1%) |
| Jun 2022 | - | -$18.51 M(-8.6%) | -$72.06 M(-1.1%) |
| Mar 2022 | - | -$20.25 M(+6.2%) | -$72.83 M(+1.8%) |
| Dec 2021 | -$71.52 M(+18.8%) | -$19.07 M(+34.0%) | -$71.52 M(+1.8%) |
| Sep 2021 | - | -$14.23 M(-26.2%) | -$70.26 M(-0.8%) |
| Jun 2021 | - | -$19.28 M(+1.8%) | -$70.85 M(+12.4%) |
| Mar 2021 | - | -$18.94 M(+6.4%) | -$63.04 M(+4.7%) |
| Dec 2020 | -$60.18 M | -$17.81 M(+20.1%) | -$60.18 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$14.82 M(+29.3%) | -$51.70 M(+4.0%) |
| Jun 2020 | - | -$11.47 M(-28.7%) | -$49.73 M(-5.4%) |
| Mar 2020 | - | -$16.08 M(+72.5%) | -$52.56 M(+9.0%) |
| Dec 2019 | -$48.23 M(+89.7%) | -$9.32 M(-27.5%) | -$48.23 M(+58.3%) |
| Sep 2019 | - | -$12.85 M(-10.1%) | -$30.47 M(+18.2%) |
| Jun 2019 | - | -$14.30 M(+21.7%) | -$25.79 M(+3.2%) |
| Mar 2019 | - | -$11.75 M(-239.4%) | -$24.99 M(-1.7%) |
| Dec 2018 | -$25.42 M(-8.9%) | $8.43 M(-203.2%) | -$25.42 M(-45.6%) |
| Sep 2018 | - | -$8.17 M(-39.5%) | -$46.74 M(+7.0%) |
| Jun 2018 | - | -$13.51 M(+10.9%) | -$43.68 M(+19.5%) |
| Mar 2018 | - | -$12.18 M(-5.5%) | -$36.56 M(+31.0%) |
| Dec 2017 | -$27.91 M(+28.6%) | -$12.89 M(+152.3%) | -$27.91 M(+85.8%) |
| Sep 2017 | - | -$5.11 M(-20.0%) | -$15.02 M(+51.5%) |
| Jun 2017 | - | -$6.39 M(+81.0%) | -$9.91 M(+181.0%) |
| Mar 2017 | - | -$3.53 M | -$3.53 M |
| Dec 2016 | -$21.71 M(+97.6%) | - | - |
| Dec 2015 | -$10.99 M | - | - |
FAQ
- What is X4 Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual FCF year-on-year change?
- What is X4 Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly FCF year-on-year change?
- What is X4 Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM FCF year-on-year change?
What is X4 Pharmaceuticals annual free cash flow?
The current annual FCF of XFOR is -$96.57 M
What is the all time high annual FCF for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual free cash flow is -$10.99 M
What is X4 Pharmaceuticals annual FCF year-on-year change?
Over the past year, XFOR annual free cash flow has changed by -$19.37 M (-25.09%)
What is X4 Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of XFOR is -$34.12 M
What is the all time high quarterly FCF for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly free cash flow is $8.43 M
What is X4 Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, XFOR quarterly free cash flow has changed by +$3.29 M (+8.79%)
What is X4 Pharmaceuticals TTM free cash flow?
The current TTM FCF of XFOR is -$132.97 M
What is the all time high TTM FCF for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM free cash flow is -$3.53 M
What is X4 Pharmaceuticals TTM FCF year-on-year change?
Over the past year, XFOR TTM free cash flow has changed by -$13.29 M (-11.10%)